| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 10, 2025 | Active | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| CARBON, TOTAL | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 3.009 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 3.009 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 3.009 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 3.009 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 10, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 8, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 8, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| CARBON, TOTAL | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| CARBON, TOTAL | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Groundwater Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |